Treatmentexperimental

Epitalon Therapy

A synthetic tetrapeptide marketed as a telomerase-activating 'anti-aging' peptide claimed to lengthen telomeres, regulate melatonin/circadian rhythm and extend lifespan.

A synthetic tetrapeptide marketed as a telomerase-activating 'anti-aging' peptide claimed to lengthen telomeres, regulate melatonin/circadian rhythm and extend lifespan. Sold as short injectable courses, sometimes 1-2 times yearly.

Evidence

experimental

Lifespan and telomere claims rest on small, dated Russian studies and animal data that have not been independently replicated in rigorous human trials, so the longevity claim is unproven.

Regulatory notes

European Union
No EMA/AEMPS authorisation; no legal approved human product in Spain/EU.
United States
Not FDA-approved for human use; FDA proposed that epitalon NOT be added to the 503A Bulks List, so it cannot be lawfully compounded and is sold only as a research chemical.
United Arab Emirates
Not DHA/DoH-registered; unauthorised as a licensed medicine.
United Kingdom
Not MHRA-licensed for human use; only lawful outside approved-medicine channels as a research substance.

General information, not medical or legal advice. See our disclaimer.

Also known as

epithalon, epithalone, epitalon acetate, AEDG peptide, Ala-Glu-Asp-Gly

Where to find it

40 clinics in the directory offer epitalon therapy. Prices shown are the cheapest for this treatment where published; always confirm with the venue.

Back to glossary